Citigroup »

Theravance Biopharma shares owned by Citigroup

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $166k 15k 11.24
2023-09-30 $48k 5.6k 8.63
2023-03-31 $77k 7.0k 10.85
2022-12-31 $90k 8.0k 11.22
2022-09-30 $0 12k 0.00
2021-12-31 $226k 21k 11.04
2021-03-31 $127k 6.3k 20.18
2020-12-31 $371k 21k 17.77
2020-09-30 $142k 9.7k 14.72
2020-06-30 $823k 39k 21.12
2020-03-31 $438k 19k 23.45
2019-12-31 $549k 14k 40.00
2019-09-30 $0 7.1k 0.00
2019-06-30 $231k 14k 16.30
2019-03-31 $284k 13k 22.55
2018-12-31 $166k 6.5k 25.61
2018-09-30 $59k 1.8k 32.63
2018-06-30 $9.0k 376 23.94
2018-03-31 $5.0k 218 22.94
2017-12-31 $10k 358 27.93
2017-09-30 $332k 9.7k 34.26
2017-06-30 $8.0k 190 42.11
2017-03-31 $2.4M 66k 36.81
2016-12-31 $593k 19k 31.90
2016-09-30 $213k 5.9k 36.22
2016-06-30 $156k 6.9k 22.69
2015-12-31 $178k 11k 16.36
2015-09-30 $0 4 0.00
2015-06-30 $70k 5.4k 13.03
2014-09-30 $42k 1.8k 23.23